These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26043560)

  • 21. Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial.
    Panahi Y; Kianpour P; Mohtashami R; Atkin SL; Butler AE; Jafari R; Badeli R; Sahebkar A
    Phytother Res; 2018 Jul; 32(7):1382-1387. PubMed ID: 29520889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical observation on treatment of nonalcoholic fatty liver disease complicating hyperuricemia by Zhifang I Decoction].
    Zhang XY; Kuang CB
    Zhong Xi Yi Jie He Xue Bao; 2004 Jul; 2(4):265-7, 313. PubMed ID: 15339411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].
    Duan SH; Bao ZY; Yuan XD; Wang L; Liu MS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):535-8. PubMed ID: 27386642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
    Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
    Khonche A; Huseini HF; Gholamian M; Mohtashami R; Nabati F; Kianbakht S
    J Ethnopharmacol; 2019 Apr; 234():106-111. PubMed ID: 30639231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review.
    Zhang X; Jiang Z; Jin X; Zhou Q
    Medicine (Baltimore); 2024 Feb; 103(5):e37052. PubMed ID: 38306552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study].
    Mao YM; Zeng MD; Li YM; Wang BY; Shang J; Shi RH; Liu JY; Lu LG; Cao AP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):213-6. PubMed ID: 19335986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.
    Cheng F; Ma C; Wang X; Zhai C; Wang G; Xu X; Mu J; Li C; Wang Z; Zhang X; Yue W; Du X; Lian Y; Zhu W; Yin X; Wei Z; Song W; Wang Q
    BMC Complement Altern Med; 2017 Apr; 17(1):203. PubMed ID: 28388904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments.
    Garcia-Beltran C; Peyrou M; Navarro-Gascon A; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
    Front Endocrinol (Lausanne); 2024; 15():1325230. PubMed ID: 38818508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
    Aller R; De Luis DA; Izaola O; Conde R; Gonzalez Sagrado M; Primo D; De La Fuente B; Gonzalez J
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1090-5. PubMed ID: 22013734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.
    Kobyliak N; Abenavoli L; Mykhalchyshyn G; Kononenko L; Boccuto L; Kyriienko D; Dynnyk O
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):41-49. PubMed ID: 29557414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial.
    Behrouz V; Aryaeian N; Zahedi MJ; Jazayeri S
    J Food Sci; 2020 Oct; 85(10):3611-3617. PubMed ID: 32885440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial.
    Hui D; Liu L; Azami NLB; Song J; Huang Y; Xu W; Wu C; Xie D; Jiang Y; Bian Y; Sun M
    Front Endocrinol (Lausanne); 2022; 13():1107071. PubMed ID: 36743913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.